Lista de obras -

3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis.

artículo científico publicado en 2013

A flexible approach to the design of new potent substance P receptor ligands

artículo científico publicado en 2001

Antitrypanosomal activities and cytotoxicity of 5-nitro-2-furancarbohydrazides.

artículo científico publicado en 2002

Benzo[d]thiazol-2(3H)-ones as new potent selective CB2 agonists with anti-inflammatory properties

artículo científico publicado en 2018

Conformation of the tripeptide Cbz-Pro-Leu-Trp-OBzl(CF3)2 deduced from two-dimensional 1H-NMR and conformational energy calculations is related to its affinity for NK1-receptor.

artículo científico publicado en 2001

Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis.

artículo científico publicado en 2014

Corrigendum to “Evaluation and comparison of three different separation techniques for analysis of retroamide enantiomers and their biological evaluation against h -P2X7 receptor” [J. Chromatogr. B 986–987 (2015) 35–43]

scientific article published on 24 May 2016

Design, synthesis and biological evaluation of potent FAAH inhibitors

artículo científico publicado en 2016

Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping.

artículo científico publicado en 2018

Du cannabis aux agonistes sélectifs du récepteur CB2

artículo científico publicado en 2013

Evaluation and comparison of three different separation techniques for analysis of retroamide enantiomers and their biological evaluation against h-P2X7 receptor

artículo científico publicado en 2015

In vitro and in vivo evaluation of two rational-designed nonpeptidic farnesyltransferase inhibitors on HT29 human colon cancer cell lines

artículo científico publicado en 2005

Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential.

artículo científico publicado en 2015

Microwave-mediated synthesis and manipulation of a 2-substituted-5-aminooxazole-4-carbonitrile library

New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis

artículo científico publicado en 2011

Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.

artículo científico publicado en 2006

Novel potent substance P and neurokinin A receptor antagonists. Conception, synthesis and biological evaluation of indolizine derivatives

artículo científico publicado en 2002

One- or Two-Step Synthesis of C-8 and N-9 Substituted Purines

artículo científico publicado en 2017

Potent farnesyltransferase inhibitors with 1,4-diazepane scaffolds as novel destabilizing microtubule agents in hormone-resistant prostate cancer.

artículo científico publicado en 2011

Recent advances in the development of selective CB(2) agonists as promising anti-inflammatory agents.

artículo científico

Scaffold hopping strategy toward original pyrazolines as selective CB2 receptor ligands

artículo científico publicado en 2012

Small scale separation of isoxazole structurally related analogues by chiral supercritical fluid chromatography

scientific article published on 12 May 2017

Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds.

artículo científico publicado en 2006

Switching cannabinoid response from CB2 agonists to FAAH inhibitors

artículo científico publicado en 2014

Switching invariant natural killer T (iNKT) cell response from anticancerous to anti-inflammatory effect: molecular bases.

artículo científico

Synthesis and biological activity of N-aroyl-tetrahydro-gamma-carbolines.

artículo científico publicado en 2010

Synthesis and biological evaluation of ferrocene-based cannabinoid receptor 2 ligands.

artículo científico publicado en 2018

Synthesis of 2,3 and 4,5-Dihydro-hydroxy-isoxazoles and Isoxazoles Under Different pH Conditions

Synthesis of Bioorganometallic Nanomolar-Potent CB2 Agonists Containing a Ferrocene Unit

Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.

artículo científico

Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.

artículo científico publicado en 2016

Therapeutical potential of CB₂ receptors in immune-related diseases

artículo científico publicado en 2013

Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR features.

artículo científico publicado en 2013

Lista de obras de

3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis.

A flexible approach to the design of new potent substance P receptor ligands

Antitrypanosomal activities and cytotoxicity of 5-nitro-2-furancarbohydrazides.

Benzo[d]thiazol-2(3H)-ones as new potent selective CB2 agonists with anti-inflammatory properties

Conformation of the tripeptide Cbz-Pro-Leu-Trp-OBzl(CF3)2 deduced from two-dimensional 1H-NMR and conformational energy calculations is related to its affinity for NK1-receptor.

Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis.

Corrigendum to “Evaluation and comparison of three different separation techniques for analysis of retroamide enantiomers and their biological evaluation against h -P2X7 receptor” [J. Chromatogr. B 986–987 (2015) 35–43]

Design, synthesis and biological evaluation of potent FAAH inhibitors

Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping.

Du cannabis aux agonistes sélectifs du récepteur CB2

Evaluation and comparison of three different separation techniques for analysis of retroamide enantiomers and their biological evaluation against h-P2X7 receptor

In vitro and in vivo evaluation of two rational-designed nonpeptidic farnesyltransferase inhibitors on HT29 human colon cancer cell lines

Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential.

Microwave-mediated synthesis and manipulation of a 2-substituted-5-aminooxazole-4-carbonitrile library

New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis

Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.

Novel potent substance P and neurokinin A receptor antagonists. Conception, synthesis and biological evaluation of indolizine derivatives

One- or Two-Step Synthesis of C-8 and N-9 Substituted Purines

Potent farnesyltransferase inhibitors with 1,4-diazepane scaffolds as novel destabilizing microtubule agents in hormone-resistant prostate cancer.

Recent advances in the development of selective CB(2) agonists as promising anti-inflammatory agents.

Scaffold hopping strategy toward original pyrazolines as selective CB2 receptor ligands

Small scale separation of isoxazole structurally related analogues by chiral supercritical fluid chromatography

Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds.

Switching cannabinoid response from CB2 agonists to FAAH inhibitors

Switching invariant natural killer T (iNKT) cell response from anticancerous to anti-inflammatory effect: molecular bases.

Synthesis and biological activity of N-aroyl-tetrahydro-gamma-carbolines.

Synthesis and biological evaluation of ferrocene-based cannabinoid receptor 2 ligands.

Synthesis of 2,3 and 4,5-Dihydro-hydroxy-isoxazoles and Isoxazoles Under Different pH Conditions

Synthesis of Bioorganometallic Nanomolar-Potent CB2 Agonists Containing a Ferrocene Unit

Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.

Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.

Therapeutical potential of CB₂ receptors in immune-related diseases

Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR features.